Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, ...

Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, ...

Chinese Vice Premier He Lipeng began talks with U.S. Treasury Secretary Scott Bessent early on Saturday in Geneva in a ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

Shares of Bristol Myers Squibb Co. BMY slipped 1.55% to $46.88 Thursday, on what proved to be an all-around positive trading ...

Shares of Bristol Myers Squibb Co. BMY shed 1.01% to $50.06 Monday, on what proved to be an all-around grim trading session ...

(Reuters) -Bristol Myers Squibb said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks ...

My shift schedule allowed me to allocate time to complete my third-level education - a biopharmaceutical processing degree at ...

A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...

The U.S. Food and Drug Administration (FDA) on Monday cleared the amendment to Lantern Pharma Inc.’s (NASDAQ:LTRN) Investigational New Drug (IND) application for the Phase 1b/2 trial of LP-184 in a ...

Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here to find out why BMY stock is a Buy.